Increased prevalence of autoimmune phenomena in myelofibrosis: Relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns

Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Francesca Guia Imperiali(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Francesca Guidotti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Dario Consonni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Paola Bianchi(University of Pavia), Bruno Fattizzo(University of Milan), Elisa Fermo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Anna Zaninoni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Tommaso Radice(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alessandra Iurlo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Leukemia Research
September 12, 2013
10.1016/j.leukres.2013.09.001
Cited by 40

Related Papers

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
|The American Journal of Human Genetics|2009|510
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
|The American Journal of Human Genetics|2011|506
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
|Blood|2009|433
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394